» Articles » PMID: 22138086

Interleukin-6 Signalling: More Than Jaks and STATs

Overview
Journal Eur J Cell Biol
Publisher Elsevier
Specialty Cell Biology
Date 2011 Dec 6
PMID 22138086
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

The hallmark of signalling by many cytokines is the activation of the Janus kinase (Jak)/signal transducer and activator of transcription (STAT) pathway. However, cytokines additionally activate other pathways. In past years we realised that these pathways significantly contribute to the physiological functions of IL-6 and pathophysiological functions in the context of many inflammatory and proliferative diseases. Whereas other articles in this issue of the European Journal of Cell Biology focus on STAT activation and its regulation we here aim to summarise our knowledge and some remaining questions on interleukin-6 (IL-6)-induced STAT-independent pathways as well as the cross-talk with the Jak/STAT pathway. In the early stages of studying cytokine signalling we were used to analysing individual signalling pathways. These days we know about the importance of both, the crosstalk between pathways initiated by combinations of cytokines as well as the crosstalk between individual pathways initiated by a single cytokine. Whereas the inter-cytokine crosstalk can be studied relatively easily, more sophisticated experimental approaches are required to elucidate the intra-cytokine crosstalk.

Citing Articles

Human Recombinant Interleukin-6 and Leukemia Inhibitory Factor Improve Inner Cell Mass Cell Number but Lack Cryoprotective Activities on In Vitro-Produced Bovine Blastocysts.

Oliver M, Alward K, Rhoads M, Ealy A Animals (Basel). 2025; 15(5).

PMID: 40075953 PMC: 11899334. DOI: 10.3390/ani15050668.


No evidence for paradoxical effects of tocilizumab in rodents.

Garbers C Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40072557 DOI: 10.1007/s00210-025-04021-1.


Il-6 signaling exacerbates hallmarks of chronic tendon disease by stimulating reparative fibroblasts.

Stauber T, Moschini G, Hussien A, Jaeger P, De Bock K, Snedeker J Elife. 2025; 12.

PMID: 39918402 PMC: 11805502. DOI: 10.7554/eLife.87092.


VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis.

Waddell S, Zhao G, Liu Z, Chen H, Zhang W, Wang Y J Pharmacol Exp Ther. 2025; 392(1):100006.

PMID: 39893008 PMC: 11808928. DOI: 10.1124/jpet.124.002298.


Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis.

Zhou Y, Ling T, Shi W Respir Res. 2024; 25(1):245.

PMID: 38886743 PMC: 11184855. DOI: 10.1186/s12931-024-02878-z.